Conversely, in mice fed a high-fat diet, adenoviral-mediated overexpression of ChREBP in the liver improves glucose tolerance and insulin sensitivity, although hepatic steatosis is induced through activation of FAS, ACC, and SCD1 expression. Here, MLXIPL is linked to fatty liver disease.